NR3C2 and obesity disorder: Studies have shown that the presence of metabolic abnormalities such as obesity, insulin resistance, and increased aldosterone levels, favors MR activation, which further promotes vascular endothelial dysfunction and accelerates arterial stiffness and atherosclerosis [53,54].